Roy D. Baynes
Disclosed holdings of Roy D. Baynes as of 2024-11-15: 16K shares of Natera (NTRA), worth about $6.31M at the last close and 1 other company. From SEC Form 4…
What Roy D. Baynes reported holding
As of the latest filing on , Roy D. Baynes reported holding 15,807 shares of Natera (NTRA), worth about $6.31M at the last close of $399 (Oct 19, 2026). Holdings are also on file at Travere Therapeutics (TVTX); together they are worth about $7.88M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Natera NTRA | 15,807 | 16K direct | $399 | $6.31M | Nov 15, 2024 |
| Travere Therapeutics TVTX | 31,000 | 31K direct | $50 | $1.57M | Feb 6, 2025 |
Is this Roy D. Baynes’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2020
Roy D. Baynes has no open-market purchase on record since 2020 across 2 companies. Sales in 3 of the 7 years since 2020.
Roy D. Baynes reported 0 open-market purchases and 9 sales since 2020; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | 2×2 trades |
| 2024 | — | 6×6 trades |
| 2020 | — | 1×1 trade |
Insider at 2 companies
- Travere Therapeutics TVTX2025 · 0 purchases, 2 sales
- Natera NTRA2020–2024 · 0 purchases, 7 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The companies behind these filings
- Natera NTRA
Roy D. Baynes reported 0 open-market purchases and 7 sales here, 2020 to 2024.
- Market value
- $57.6B
- Last close
- $399.42
- 12 months
- +119.8%
- Against the S&P 500
- +104.5 pts
- Net margin
- -9.0%
- Revenue (last year)
- $2.31B
- Travere Therapeutics TVTX
Roy D. Baynes reported 0 open-market purchases and 2 sales here, 2025.
- Market value
- $4.76B
- Last close
- $50.49
- 12 months
- +84.8%
- Against the S&P 500
- +69.4 pts
- Net margin
- -5.2%
- Revenue (last year)
- $491M
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Roy D. Baynes's trades
Has Roy D. Baynes bought shares on the open market?
Roy D. Baynes has no open-market purchase on record since 2020 across 2 companies. Sales in 3 of the 7 years since 2020.
When did Roy D. Baynes last buy or sell shares?
In SEC filings since 2020: no open-market purchase is on record; the latest open-market sale is from 2025.
Which companies has Roy D. Baynes traded as an insider?
2 companies: Travere Therapeutics (TVTX, 2025), Natera (NTRA, 2020–2024).